{"id":"W4401723588","doi":"10.1001/jamadermatol.2024.2701","title":"Tyrosine Kinase 2 Inhibition With Zasocitinib (TAK-279) in Psoriasis","year":2024,"lang":"en","type":"article","venue":"JAMA Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":42,"is_retracted":false,"has_abstract":true,"ca_institutions":"Innovaderm (Canada); University of Toronto; Lynde Centre for Dermatology; Probity Medical Research","funders":"","keywords":"Medicine; Psoriasis Area and Severity Index; Psoriasis; Tolerability; Randomized controlled trial; Placebo; Internal medicine; Clinical endpoint; Body surface area; Adverse effect; Clinical trial; Dermatology; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001021051,0.0003793471,0.001161748,0.0002153256,0.0002148724,0.0003856604,0.0002525785,0.0003846727,0.001840131],"category_scores_gemma":[0.0006044458,0.0001717452,0.0004520023,0.0002585575,0.0003401011,0.0003416209,0.0001480403,0.001039796,0.000243139],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00033427,"about_ca_system_score_gemma":0.000796292,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008015399,"about_ca_topic_score_gemma":0.002565739,"domain_scores_codex":[0.999741,0.000125839,0.00002798114,0.00003043448,0.00004260162,0.00003219651],"domain_scores_gemma":[0.9997385,0.00008275129,0.00007908483,0.00001026339,0.0000181482,0.00007122018],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5313762,0.01253126,0.01022114,0.004904464,0.00143145,0.0003023639,0.0001650963,0.002733801,0.0679411,0.0003137699,0.003592591,0.3644868],"study_design_scores_gemma":[0.6114983,0.3161069,0.04090927,0.0003409684,0.001974926,0.001264991,0.0001353229,0.00354127,0.01559217,0.0004330623,0.008159547,0.00004343418],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.978799,0.01758288,0.0006781114,0.0004076899,0.0001121075,0.0006850228,0.0002004375,0.00005881304,0.001475919],"genre_scores_gemma":[0.9900808,0.007288525,0.0010564,0.0002397461,0.0001676781,0.0003778144,0.0001892734,0.000005053194,0.0005947116],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001840131,"threshold_uncertainty_score":0.006155908,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01175911386873733,"score_gpt":0.2343829810614381,"score_spread":0.2226238671927008,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}